番茄社区app

Liver cells damaged by diet-driven metabolic dysfunction are like a "ticking time bomb" in the evolution of , according to a study in . (UC San Diego)

Viracta Therapeutics announced the of its combination therapy of the histone deacetylase inhibitor nanatinostat and the antiviral agent valganciclovir for relapsed/refractory Epstein-Barr virus-positive lymphomas to "explore a broad range of strategic alternatives."

Former President Jimmy Carter had a lasting impact on the development and awareness of . (NBC News)

STAT reported on the waning reliance on for hematologic malignancies.

An editorial cautioned about direct-to-consumer tests for . (Oncotarget)

Clinical practice experience with pembrolizumab (Keytruda) for provided new insights into the use, benefits, and potential side effects of the treatment. (Cleveland Clinic)

A California oncologist agreed to pay $3 million to the U.S. Securities and Exchange Commission to settle allegations of related to the doctor's research on a new cancer drug. (Mondaq)

A "speckle" of evidence may help explain and others do not. (Cold Spring Harbor Laboratory)

Expected during the first half of 2025, data from could have an impact on cancer and other diseases. (Biopharma Dive)

are projected to drive innovation in the drug-development pipeline for the next 5 years. (GlobalData)

Advanced or metastatic breast cancer, besides posing its own threat, might also signal . (University of Texas MD Anderson Cancer Center)

Comment